In TRIUMPH-4, 20.9% of participants on the 12mg dose reported dysesthesia , compared to just 0.7% on placebo
Medication overuse headache, sometimes called rebound headache, is a real phenomenon where taking pain relievers too frequently actually causes more headaches
We designed the glycine biosensor using benchling to make it compatible with Type IIs assembly, with BsaI restriction sites and fusion sites compatible with a DVK-AF destination plasmid (Figure 2)
In rodent models, Melanotan II reduced food intake, body weight, and fat mass under experimental conditions
Weeks 5-16: The ramp-up to efficacy During this phase, the dose is gradually increased every few weeks
We're here to support every step of your scientific journey